Rallybio names Lieber Chief Financial Officer
Rallybio reports that Jonathan I. Lieber has joined the company as Chief Financial Officer, effective February 1. Mr. Lieber succeeds Jeffrey Fryer, CPA, Rallybio’s Co-Founder and...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Rallybio reports that Jonathan I. Lieber has joined the company as Chief Financial Officer, effective February 1. Mr. Lieber succeeds Jeffrey Fryer, CPA, Rallybio’s Co-Founder and...
With several key approvals in recent weeks, plans to redevelop sections of the former Winchester firearms factory at New Haven’s Science Park are moving forward with a...
Connecticut Governor Ned Lamont has made workforce development a key issue going into his second term, and his two-year, $50.5 billion budget proposal sets aside tens of millions...
New Haven biotech company Halda Therapeutics reports positive results in preclinical trials of its oral candidate for the treatment of prostate cancer. Halda is developing a novel...
Cara Therapeutics reports that the New England Journal of Medicine (NEJM) has published results from the KOMFORT Phase 2 clinical trial of oral difelikefalin in...
View this email in your browser February 16, 2023 Women in Bio – Boardroom Ready Application, March 15, 2023 The Boardroom Ready platform is rooted...
UConn School of Medicine Assistant Professor of Immunology Zhichao Fan is leading groundbreaking research into the novel use of a leukocyte-inhibiting drug to reduce tissue damage...
BioXcel Therapeutics is reporting full data from its Phase 2a trial of BXCL701, the Company’s investigational, oral innate immune activator, in combination with KEYTRUDA® (pembrolizumab) in...
The biotechnology company Abryx has announced that it will open a manufacturing and distribution operation in Stamford, CT. It will lease 7,000 square feet of space and plans...
More than two dozen New Haven city officials and local public-education leaders gathered in the library of Career High School at 140 Legion Ave. to...